TABLE 2:
First Author [Reference No.] | RT |
MRI Acquisition |
MRI Interpretaron |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Type | Dose (Gy) | ADT, % (No./Total No.) | Vendor | Model | Magnet Strength (T) | Endorectal Coil | Sequences | No. of Readers | Consensus Reading | Reader Experience (y) | |
Clarke [24] | E and B, B | E and B, 45–50.4; B, 90–115 | 37(144/390) | NR | NR | NR | Yes | T2-weighted imaging | 3 | No | NR |
Fuchsjäger [25] | E | 81–86.4 | 54(121/224) | GE | Signa Horizon | 1.5 | Yes | T2-weighted imaging | 2 | Yes | 5,1.5 |
Gnep [26] | E | 74–80 | 57(42/74) | Philips | Achieva | 3 | No | T2-weighted imaging, DWI, DCE-MRI | 2 | Yes | 5,30 |
Gomez-Iturriaga [27] | E and B | E, 37.5; B, 15 | All | Philips | Achieva | 1.5 | No | T2-weighted imaging, DWI, DCE-MRI | 2 | Yes | Specialist |
Goupy [28] | E | 70–80 | All | NR | NR | 1.5 | No | T2-weighted imaging, DWI, DCE-MRI | 2 | No | Expert |
Hegde [29] | E and B | E, 39.6–50.4; B, 15–24 | 81(30/37) | NR | NR | 3 | Yes for some patients | T2-weighted imaging, DWI, DCE-MRI | NR | NR | NR |
Jackson [30] | E | 60–74 | All | Siemens | GBS1, Vision | 1.5 | No | T2-weighted imaging | 1 | NA | Consultant |
Joseph [31] | E | 68–76 | 58(39/67) | Siemens | Signa | 1.5 | Yes | T2-weighted imaging, MRS | 1 | NA | >10 |
Kauffmann [32] | E or B or both E and B | E, 75.6–79.2; B, 144–145 | 52(64/123) | Philips | Achieva | 1.5,3 | No | T2-weighted imaging | 2 | NR | Body imaging |
Nguyen [33] | E | 70–72 | None | GE | NR | 1.5 | Yes | T2-weighted imaging | 3 | No | >4 |
Riaz [34] | E and B | E, 50.4; B, LDR of 90–110 or HDRof 16.5–22.5 | 36(100/279) | GE | Signa Horizon | 1.5,3 | Yes | T2-weighted imaging | 2 | Yes | GU radiologist |
Yamaguchi [35] | E | 70–78 | 76(77/101) | NR | NR | 1.5,3 | NR | T2-weighted imaging, DWI | 2 | Yes | 3,20 |
Note—ADT = androgen deprivation treatment, E = external beam RT, B = brachytherapy, NR = not reported, DCE-MRI = dynamic contrast-enhanced MRI, NA = not applicale, MRS = MR spectroscopy, LDR = low-dose rate, HDR = high-dose rate, GU = genitourinary.